JGCM
ELV icon

Joseph Group Capital Management’s Elevance Health ELV Stock Holding History

Joseph Group Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Buy
56
+35
+167% +$13K ﹤0.01% 225
2026
Q1 		$6.15K Buy
21
+1
+5% +$329 ﹤0.01% 357
2025
Q4 		$7.01K Buy
+20
New +$6.76K ﹤0.01% 229

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Joseph Group Capital Management's ELV Position: Q2 2026 in Review

Joseph Group Capital Management increased its Elevance Health (ELV) stake by 167% in Q2 2026, buying an estimated $13K and bringing the position to 56 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #225.

Joseph Group Capital Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Joseph Group Capital Management held 56 shares of Elevance Health worth $21.7K as of Q2 2026.
  • Joseph Group Capital Management bought 35 Elevance Health shares in Q2 2026, an estimated $13K.
  • Elevance Health made up ﹤0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #225 holding.
  • Joseph Group Capital Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.